US 11,746,334 B2
Adenoviruses and methods for using adenoviruses
Michael A. Barry, Rochester, MN (US)
Assigned to MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Rochester, MN (US)
Filed by MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, Rochester, MN (US)
Filed on Nov. 21, 2019, as Appl. No. 16/690,733.
Claims priority of provisional application 62/770,631, filed on Nov. 21, 2018.
Prior Publication US 2020/0157510 A1, May 21, 2020
Int. Cl. C12N 7/00 (2006.01); A61K 35/761 (2015.01)
CPC C12N 7/00 (2013.01) [A61K 35/761 (2013.01); C12N 2750/14122 (2013.01); C12N 2750/14132 (2013.01); C12N 2750/14143 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A recombinant adenovirus (Ad), wherein capsid hexon polypeptides of an Ad strain Ad6 comprise at least two capsid hexon hypervariable region (HVR) polypeptides from Ad strain Ad57.